Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Quick stroke lessons could save lives: One-Week campaign tested

NCT ID NCT07578259

Knowledge-focused Sponsor: University of Baghdad Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a one-week educational campaign called SURA'A can improve how adults recognize stroke symptoms and their intention to seek emergency help. Researchers will enroll 350 adults at primary health centers in Diwaniyah. Participants will receive targeted consultations and educational materials, and their knowledge will be measured before and after the campaign using a validated test.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
SURA'A Consultation-Based Campaign (educational program)
What this could lead to
If successful, this campaign could be a simple, low-cost way to help more people recognize stroke symptoms and call for emergency help quickly.
What could go wrong
This is a small, early-stage study with only 350 participants. The campaign lasts just one week, so any improvements may not last long or apply to other communities.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 350 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Jun 2026

An estimate. Start dates often move.

Expected to finish

Apr 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria Participants will be eligible if they: 1. Age * Adults aged ≥18 years residing in Diwaniyah. 2. Residence o Living in Diwaniyah communities for at least 6 academic months prior to the study. 3. Access to Primary Health Centers (PHCs) * Attending in selected primary health centers where the SURA'A campaign will be implemented. 4. Cognitive ability o Able to understand and answer the survey questions in Arabic. 5. Consent o Willing to provide informed consent to participate in pre- and post- awareness intervention assessments. Availability for follow-up o Agree to participate in both baseline (pre-campaign) and follow-up (post-campaign) assessments. Exclusion Criteria Participants will be excluded if they: 1. Have a previous confirmed diagnosis of stroke (to avoid bias in baseline awareness). 2. Severe cognitive impairment * Have diagnosed dementia, severe mental illness, or cognitive impairment that prevents reliable responses. 3. Communication barriers o Cannot communicate in Arabic or has severe hearing/speech impairment that prevents participation. 4. Health professionals o Physicians, nurses, paramedics, or students of medical and health colleges (to avoid overestimation of awareness). 5. Temporary visitors o Non-residents or individuals visiting Diwaniyah temporarily. 6. Refusal or withdrawal o Decline to participate or withdraw at any stage of the study.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Stroke are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

stroke disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Stroke

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  2. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

More trials for these conditions

Other studies related to the condition(s) this trial covers.